294 related articles for article (PubMed ID: 22769236)
1. Safety and efficacy outcomes of long-term treatment up to 4 years with 5% lidocaine medicated plaster in patients with post-herpetic neuralgia.
Sabatowski R; Hans G; Tacken I; Kapanadze S; Buchheister B; Baron R
Curr Med Res Opin; 2012 Aug; 28(8):1337-46. PubMed ID: 22769236
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy.
Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
Curr Med Res Opin; 2009 Jul; 25(7):1677-87. PubMed ID: 19480610
[TBL] [Abstract][Full Text] [Related]
3. 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study.
Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
Curr Med Res Opin; 2009 Jul; 25(7):1663-76. PubMed ID: 19485723
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term study.
Hans G; Sabatowski R; Binder A; Boesl I; Rogers P; Baron R
Curr Med Res Opin; 2009 May; 25(5):1295-305. PubMed ID: 19366301
[TBL] [Abstract][Full Text] [Related]
5. Long-term treatment of neuropathic pain with a 5% lidocaine medicated plaster.
Wilhelm IR; Tzabazis A; Likar R; Sittl R; Griessinger N
Eur J Anaesthesiol; 2010 Feb; 27(2):169-73. PubMed ID: 20010108
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial.
Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
Clin Drug Investig; 2009; 29(4):231-41. PubMed ID: 19301937
[TBL] [Abstract][Full Text] [Related]
7. Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational efficacy and safety trial.
Binder A; Bruxelle J; Rogers P; Hans G; Bösl I; Baron R
Clin Drug Investig; 2009; 29(6):393-408. PubMed ID: 19432499
[TBL] [Abstract][Full Text] [Related]
8. [Experience with 5% lidocaine medicated plaster in the treatment of localized neuropathic pain].
Fogliardi A; Brunori C
Minerva Med; 2013 Dec; 104(6):631-7. PubMed ID: 24316916
[TBL] [Abstract][Full Text] [Related]
9. Post-herpetic neuralgia: 5% lidocaine medicated plaster, pregabalin, or a combination of both? A randomized, open, clinical effectiveness study.
Rehm S; Binder A; Baron R
Curr Med Res Opin; 2010 Jul; 26(7):1607-19. PubMed ID: 20429825
[TBL] [Abstract][Full Text] [Related]
10. 5% lidocaine medicated plaster in elderly patients with postherpetic neuralgia: results of a compassionate use programme in France.
Clère F; Delorme-Morin C; George B; Navez M; Rioult B; Tiberghien-Chatelain F; Ganry H
Drugs Aging; 2011 Sep; 28(9):693-702. PubMed ID: 21913735
[TBL] [Abstract][Full Text] [Related]
11. Topical pain management with the 5% lidocaine medicated plaster--a review.
Mick G; Correa-Illanes G
Curr Med Res Opin; 2012 Jun; 28(6):937-51. PubMed ID: 22551228
[TBL] [Abstract][Full Text] [Related]
12. The safety and efficacy of KAI-1678- an inhibitor of epsilon protein kinase C (εPKC)-versus lidocaine and placebo for the treatment of postherpetic neuralgia: a crossover study design.
Cousins MJ; Pickthorn K; Huang S; Critchley L; Bell G
Pain Med; 2013 Apr; 14(4):533-40. PubMed ID: 23438341
[TBL] [Abstract][Full Text] [Related]
13. Lidocaine 5% medicated plaster: a review of its use in postherpetic neuralgia.
Garnock-Jones KP; Keating GM
Drugs; 2009 Oct; 69(15):2149-65. PubMed ID: 19791831
[TBL] [Abstract][Full Text] [Related]
14. Treatment of postherpetic neuralgia with 5% lidocaine medicated plaster in elderly patients - subgroup analyses from three European clinical trials.
Sabatowski R; Bösl I; König S; Buchheister B; Meier T; Baron R
Curr Med Res Opin; 2017 Mar; 33(3):595-603. PubMed ID: 28035844
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Population Pharmacokinetic Properties of Lidocaine and its Metabolites After Long-Term Multiple Applications of a Lidocaine Plaster in Post-Herpetic Neuralgia Patients.
Bursi R; Piana C; Grevel J; Huntjens D; Boesl I
Eur J Drug Metab Pharmacokinet; 2017 Oct; 42(5):801-814. PubMed ID: 28078530
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale.
Argoff CE; Galer BS; Jensen MP; Oleka N; Gammaitoni AR
Curr Med Res Opin; 2004; 20 Suppl 2():S21-8. PubMed ID: 15563743
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of a metered-dose 8% lidocaine pump spray for patients with post-herpetic neuralgia.
Kanai A; Kumaki C; Niki Y; Suzuki A; Tazawa T; Okamoto H
Pain Med; 2009; 10(5):902-9. PubMed ID: 19682274
[TBL] [Abstract][Full Text] [Related]
18. 5% lidocaine medicated plasters vs. sympathetic nerve blocks as a part of multimodal treatment strategy for the management of postherpetic neuralgia: a retrospective, consecutive, case-series study.
Malec-Milewska M; Horosz B; Sękowska A; Kolęda I; Kucia H; Kosson D
Neurol Neurochir Pol; 2015; 49(1):24-8. PubMed ID: 25666769
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of 5% lidocaine-medicated plasters in localized pain with neuropathic and/or inflammatory characteristics: an observational, real-world study.
Amato F; Duse G; Consoletti L; Lo Presti C; Firetto V; Ciliberto G; Parigi LA; Palmieri V; Mazza M
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4228-4235. PubMed ID: 29028074
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of a lidocaine 5% medicated plaster relative to gabapentin for postherpetic neuralgia in the United Kingdom.
Dakin H; Nuijten M; Liedgens H; Nautrup BP
Clin Ther; 2007 Jul; 29(7):1491-507. PubMed ID: 17825701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]